On Monday, Atyr Pharma Inc (NASDAQ: ATYR) was -4.60%% drop from the session before settling in for the closing price of $5.22. A 52-week range for ATYR has been $1.42 – $5.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.28%. When this article was written, the company’s average yearly earnings per share was at 28.86%. With a float of $86.06 million, this company’s outstanding shares have now reached $89.00 million.
Let’s determine the extent of company efficiency that accounts for 59 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Atyr Pharma Inc stocks. The insider ownership of Atyr Pharma Inc is 3.31%, while institutional ownership is 69.43%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 28.86% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
You can see what Atyr Pharma Inc (ATYR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Looking closely at Atyr Pharma Inc (NASDAQ: ATYR), its last 5-days average volume was 2.61 million, which is a jump from its year-to-date volume of 1.53 million. As of the previous 9 days, the stock’s Stochastic %D was 13.74%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 72.83%, which indicates a significant increase from 23.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.20% in the past 14 days, which was lower than the 87.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.97, while its 200-day Moving Average is $3.33. However, in the short run, Atyr Pharma Inc’s stock first resistance to watch stands at $5.15. Second resistance stands at $5.32. The third major resistance level sits at $5.43. If the price goes on to break the first support level at $4.87, it is likely to go to the next support level at $4.76. Now, if the price goes above the second support level, the third support stands at $4.59.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are 89,004K outstanding shares of the company, which has a market capitalization of 443.24 million. As of now, sales total 240 K while income totals -64,020 K. Its latest quarter income was 0 K while its last quarter net income were -14,880 K.
